Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CytRx
Biotech
Orphazyme on last legs amid restructuring, more layoffs
The wheels are almost entirely off Danish biotech Orphazyme after the company’s board of directors called for a court-mediated restructuring.
Max Bayer
Mar 10, 2022 6:24pm
NantCell in $356M deal for underperforming CytRx cancer drug
Jul 28, 2017 9:47am
SEC hits out at paid-for bioanalysts, CEOs and firms, charges 27
Apr 11, 2017 8:25am
Weak Phase III sarcoma results see CytRx shares crater
Jul 12, 2016 7:09am
